Eyeworld Supplements

ASCRS DIGITAL CLINICAL COMMITTEE SYMPOSIA AT THE 2025 ASCRS ANNUAL MEETING Dr. Schallhorn said that her favorite use of intraopera- tive OCT is with secondary IOLs. It can help in repositioning the haptics because it can check to see how the lens is an- gulated. Using intraoperative OCT, Dr. Schallhorn will look at the tilt of the lens relative to the iris plane and adjust to make it completely planar to the iris. Improvements in visualization drive surgical advance- ments, she said, adding that intraoperative OCT is the next frontier in surgery, and she thinks it is indispensable in complex cases. Overview of future functionality Robert Weinstock, MD, spoke about the past and future of cataract surgery in his presentation. During the last 50 years, we've had a massive evolution in technology that we have not seen in any other period of time, he said. We know when we start to see multiple companies emulating each other and pushing the boundaries that there's something there. Dr. Weinstock thinks robotic surgery is the way of the future, and he mentioned several companies developing in this space. Preceyes is one company looking at robotic eye surgery. He showed in one example that the surgeon has one instrument inside the eye and there is a robotic arm being controlled by a human hand, but the robotic arm is more precise than a human, he said. Horizon Robotics is working on a fully functional, auto- mated, AI-driven cataract machine robot. Forsight Robotics is developing technology that the surgeon would use with 3D glasses looking at a monitor. Robotic and remote surgery is on the horizon. The sur- geon will still be needed for the foreseeable future, he said, but digital imaging systems, AI, and robotics will reduce human error and lead to safer outcomes for patients. Spotlight on the NGENUITY system Arjan Hura, MD, discussed digital visualization and focused his presentation on the NGENUITY system (Alcon). This system came out in 2016, and there have been iterations almost every year for updates to software or hardware. Dr. Hura said the three critical components of the sys- tem are the HDR surgical camera, real-time image process- ing, and OLED surgical display. The real-time image processing involves taking the im- age and under- and over-exposing it to create a composite image, blending the best aspects of the individual expo- sures for optimal visualization. With the latest software, the surgeon also has the ability to enable different filter modes that can be titrated to manipulate image contrast and tone to enhance the depth and detail of visualization. This can make it easier to visualize the anterior capsule, the tra- becular meshwork, the effect of trypan blue, and improve visualization during removal of dense cataracts. Spotlight on the ARTEVO system Dr. Singh highlighted options with the ARTEVO 850 (Zeiss). The ARTEVO has a 4K HDR, 55-inch, 3D screen, 3-chip 4K cameras, and digital and hybrid mode, he said, also mentioning the augmented overlays, cataract assistance functions, phaco values (Zeiss Quatera 700), and integrated intraoperative OCT. It uses stereo coaxial illumination, so the depth of field is very good, and you can see all the way down to the middle vitreous, he said. You can change the temperature of the color saturation and use low light intensity to make it comfortable for the surgeon and patient. One of the most practical applications is the Callisto digital marking system (Zeiss) on the overlay, Dr. Singh said. ARTEVO talks to the phaco machine and Veracity planning software. One of the key differences between standard and digital scopes is you can see from the cornea down to the capsule and even to the anterior vitreous without having to adjust the focus, he said. Digital displays allow us to consolidate data that we use preoperatively, intraoperatively and postoperatively so everyone is on the same page, Dr. Singh said. Dr. Hura presented on digital visualization with the NGENUITY system. Source: ASCRS continued from previous page © Copyright 2025 ASCRS Ophthalmic Corporation. All rights reserved. The views expressed here do not necessarily reflect those of the staff and leadership of EyeWorld and ASCRS and in no way imply endorsement by EyeWorld and ASCRS.

• Cover